Physician profile
Lyly Ung
NPI 1235198631
$8,548.66
in general payments reported to CMS, 2019-2025
19 companies · $2,851 in 2025
The $2,851 reported for 2025 was more than what 94% of Low Vision Rehabilitation providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $649 · 2020: $148 · 2021: $2,657 · 2022: $457 · 2023: $915 · 2024: $871 · 2025: $2,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,410 · Travel and Lodging: $989 · Entertainment: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,409.82 |
| Travel and Lodging | $988.68 |
| Entertainment | $238.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,688.93 | 2021-2023 | Acuvue, Axert |
| Coopervision INC. | $2,279.59 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Lumenis Be INC | $1,349.42 | 2023-2025 | Optilight |
| Optos, INC. | $426.48 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $362.47 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $309.75 | 2023-2025 | Xiidra, Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $213.69 | 2025 | Xdemvy |
| Visioneering Technologies, INC. | $196.02 | 2019 | |
| Dompe US, INC. | $145.48 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $125.00 | 2021 | |
| Allergan, INC. | $119.25 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.73 | 2020 | |
| Optovue, INC. | $72.78 | 2019 | |
| Spark Therapeutics, INC. | $41.08 | 2019 | |
| Sight Sciences, INC. | $37.65 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $30.96 | 2025 | Dailies Total1 |
| Oyster Point Pharma, INC. | $25.74 | 2024 | Tyrvaya |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyly Ung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.